PUBLICATIONS
Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities
Maria G. Noval, Maria E. Kaczmarek, Akiko Koide, Bruno A. Rodriguez-Rodriguez, Ping Louie, Takuya Tada, Takamitsu Hattori, Tatyana Panchenko, Larizbeth A. Romero, Kai Wen Teng, Andrew Bazley, Maren de Vries, Marie I. Samanovic, Jeffrey N. Weiser, Ioannis Aifantis, Joan Cangiarella, Mark J. Mulligan, Ludovic Desvignes, Meike Dittmann, Nathaniel R. Landau, Maria Aguero-Rosenfeld, Shohei Koide & Kenneth A. Stapleford. Sci Rep 11, 5538 (2021).
Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies
Takuya Tada, Belinda M. Dcosta, Hao Zhou, Ada Vaill, Wes Kazmierski, Nathaniel R. Landau. Preprint in BioRxiv
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies
Takuya Tada, Belinda M Dcosta, Marie Samanovic-Golden, Ramin S Herati, Amber Cornelius, Mark J Mulligan, Nathaniel R Landau. Preprint in BioRxiv.
The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition
Takamitsu Hattori, Akiko Koide, Maria G. Noval, Tatyana Panchenko, Larizbeth A. Romero, Kai Wen Teng, Takuya Tada, Nathaniel R. Landau, Kenneth A. Stapleford, Shohei Koide, Journal of Molecular Biology,Volume 433, Issue 3, (2021),166748.
An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
Takuya Tada, Chen Fan, Chen Jennifer, Ramanjit Kaur, Kenneth A. Stapleford, Harry Gristick, Belinda M. Dcosta, Craig B. Wilen, Crina Nimigean, Nathaniel R. Landau. Cell Reports (2020) Volume 33, Issue 12, 108528.
Lentiviral-Vector-Based Dendritic Cell Vaccine Synergizes with Checkpoint Blockade to Clear Chronic Viral Infection
Thomas D. Norton, Takuya Tada, Rebecca Leibowitz, Verena van der Heide, Dirk Homann, Nathaniel R. Landau. Molecular Therapy,
Volume 28, Issue 8, 2020, Pages 1795-1805,
Lentiviral vector-based dendritic cell vaccine suppresses HIV replication in humanized mice.
Thomas D. Norton, Anjie Zhen, Takuya Tada, Jennifer Kim, Scott Kitchen, Nathaniel R. Landau. Molecular Therapy (2019), Volume 27, Issue 5, 960 - 973.
Toll-Like Receptor Agonist R848 Blocks Zika Virus Replication By Inducing The Antiviral Protein Viperin.
Vanwalscappel, Bénédicte ; Tada, Takuya; Landau, Nathaniel R. Virology. 2018 09; 522:199-208
DNA Damage Induces A SAMHD1-Mediated Block To The Infection Of Macrophages By HIV-1.
Jáuregui, Paula & Landau, Nathaniel. Scientific Reports. 2018 Mar 07; 8(1):4153
A Highly Active Isoform Of Lentivirus Restriction Factor SAMHD1 In Mouse.
Bloch, Nicolin; Glasker, Sabine; Sitaram, Poojitha; Hofmann, Henning; Shepard, Caitlin N; Schultz, Megan L; Kim, Baek; Landau, Nathaniel R. Journal Of Biological Chemistry. 2017 01 20; 292(3):1068-1080
Staphylococcus Aureus Leukocidin LukED And HIV-1 Gp120 Target Different Sequence Determinants On CCR5.
Tam, Kayan; Schultz, Megan; Reyes-Robles, Tamara; Vanwalscappel, Benedicte; Horton, Joshua; Alonzo, Francis 3rd; Wu, Beili; Landau, Nathaniel R; Torres, Victor J. MBio. 2016 12 13; 7(6):
IFN-Epsilon Protects Primary Macrophages Against HIV Infection.
Tasker, Carley; Subbian, Selvakumar; Gao, Pan; Couret, Jennifer; Levine, Carly; Ghanny, Saleena; Soteropoulos, Patricia; Zhao, Xilin; Landau, Nathaniel; Lu, Wuyuan; Chang, Theresa L. JCI Insight. 2016 12 08; 1(20):e88255
TLR7/8 Agonist Induces A Post-Entry SAMHD1-Independent Block To HIV-1 Infection Of Monocytes.
Hofmann, Henning; Vanwalscappel, Benedicte; Bloch, Nicolin; Landau, Nathaniel R. Retrovirology. 2016 Dec 01; 13(1):83
Intrinsic Host Restrictions To HIV-1 And Mechanisms Of Viral Escape.
Simon, Viviana; Bloch, Nicolin; Landau, Nathaniel R. Nature Immunology. 2015 Jun; 16(6):546-53